Home - InteKrin Therapeutics

About > The Company

Mission Statement

InteKrin Therapeutics is committed improving the health and well-being of patients with Relapsing Remitting Multiple Sclerosis.  Our goal is to bring INT131 to patients and their physicians to meet the dual needs of neuroprotection and stopping the otherwise relentless progression of this devastating disease.